e-HCG

Product NDC: 50970-001
11-digit product format: 509700001
Labeler code: 50970
Product ID: 50970-001_ac8d5688-c210-4410-8e27-5816216a8074
Type: HUMAN OTC DRUG
Nonproprietary name: arginine, acetylcarnitine, l-, ornithine and human chorionic gonadotropin
Dosage form: LIQUID
Route: ORAL
Labeler: AnuMed International LLC
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 2010-08-19
Marketing end: 0000-00-00
Substance: ARGININE; ACETYLCARNITINE, L-; ORNITHINE; HUMAN CHORIONIC GONADOTROPIN
Active strength: 30 [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50970-001		I	Inactivated by FDA	2026-10-05
excluded package	package	50970-001	50970-001-01	I	Inactivated by FDA	2026-10-05
excluded package	package	50970-001	50970-001-02	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50970-001-02	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50970-001-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50970-001-02	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50970-001-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50970-001-02	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50970-001-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50970-001-02	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50970-001-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50970-001-02	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50970-001-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50970-001-02	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50970-001-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50970-001-01	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50970-001-02	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50970-001-01	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50970-001-02	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50970-001-01	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50970-001-02	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	50970-001-01	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	50970-001-02	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	50970-001-01	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	50970-001-02	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	50970-001-01	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	50970-001-02	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	50970-001-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	50970-001-02	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	50970-001-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	50970-001-02	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	50970-001-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	50970-001-02	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	50970-001-01	I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	50970-001-02	I	Inactivated by FDA	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
08c722ec-780f-bb7b-8f14-3d4f7bf0e098	Product name	2	20240205
e2f276e5-439f-b432-b5e5-b0cfa993da69	Product name	3	20220609
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
1681bc73-b05f-12c3-1075-382ae39f449c	Product name	1	20140508
4585a4fb-0028-3d95-020c-9b1c40bf15e0	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50970-001-01	2025-01-30	e-HCG FAT RELEASE SYSTEM HOMEOPATHIC FORMULA
50970-001-02	2025-01-30	e-HCG FAT RELEASE SYSTEM HOMEOPATHIC FORMULA
50970-001-01	2023-12-08	e-HCG FAT RELEASE SYSTEM HOMEOPATHIC FORMULA
50970-001-02	2023-12-08	e-HCG FAT RELEASE SYSTEM HOMEOPATHIC FORMULA
50970-001-01	2019-10-21	e-HCG FAT RELEASE SYSTEM HOMEOPATHIC FORMULA
50970-001-02	2019-10-21	e-HCG FAT RELEASE SYSTEM HOMEOPATHIC FORMULA

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50970-001-01	e-HCGFat Release System	30 mL in 1 BOTTLE	LIQUID	30		2
50970-001-02	e-HCGFat Release System	50 mL in 1 BOTTLE	LIQUID	50		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACETYLCARNITINE, L-	ACTIVE INGREDIENT	6DH1W9VH8Q	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	1
ARGININE	ACTIVE INGREDIENT	94ZLA3W45F	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	1
HUMAN CHORIONIC GONADOTROPIN	ACTIVE INGREDIENT	20ED16GHEB	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	1
ORNITHINE	ACTIVE INGREDIENT	E524N2IXA3	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	1
ACETYLCARNITINE, L-	ACTIVE MOIETY	6DH1W9VH8Q	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	1
ARGININE	ACTIVE MOIETY	94ZLA3W45F	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	1
HUMAN CHORIONIC GONADOTROPIN	ACTIVE MOIETY	20ED16GHEB	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	1
ORNITHINE	ACTIVE MOIETY	E524N2IXA3	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50970-001	E-HCG FAT RELEASE SYSTEM (ARGININE, ACETYLCARNITINE, L-, ORNITHINE AND HUMAN CHORIONIC GONADOTROPIN) LIQUID [ANUMED INTERNATIONAL LLC]	2	Legacy NDC, 2 package rows	20231209_ac8d5688-c210-4410-8e27-5816216a8074.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
94ZLA3W45F	ARGININE	74-79-3	ARGININE
E524N2IXA3	ORNITHINE	70-26-8	ORNITHINE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
50970-001-01	50970000101	30 mL in 1 BOTTLE	30 ml	Historical
50970-001-02	50970000102	50 mL in 1 BOTTLE	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
e-HCG FAT RELEASE SYSTEM HOMEOPATHIC FORMULA	AnuMed International LLC	2023-11-29	HUMAN OTC DRUG LABEL	2